Meristem Family Wealth, LLC Eli Lilly & CO Transaction History

Meristem Family Wealth, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $1.15 Million - $1.31 Million	-3,886 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $140,344 - $174,412	-598 Reduced 13.34%	3,886 $1.11 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $33,277 - $41,297	148 Added 3.41%	4,484 $1.24 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $960,857 - $1.18 Million	4,336 New	4,336 $1 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $498,610 - $576,733	-3,410 Closed	0 $0

Q2 2020 Aug 06, 2020	BUY	$136.42 - $164.18 $6,411 - $7,716	47 Added 1.4%	3,410 $560,000
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $5,357 - $6,630	-45 Reduced 1.32%	3,363 $467,000
Q4 2019 Jan 31, 2020	SELL	$106.92 - $132.43 $37,422 - $46,350	-350 Reduced 9.31%	3,408 $448,000
Q3 2019 Nov 08, 2019	BUY	$106.79 - $116.16 $401,316 - $436,529	3,758 New	3,758 $420,000

3,725

738M

7.09M

7.24M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Meristem Family Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Meristem Family Wealth, LLC with notifications on news.